close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Ossium Health, Inc.

News headline image
Franciscan Health and Ossium Health Perform World's First Organ Donor Bone Marrow Transplant for Non-Malignant Disease
From Ossium Health, Inc.
Via GlobeNewswire
News headline image
Ossium Health to Present One-Year Outcomes in Highly Mismatched Organ Donor Bone Marrow Transplants at ASH 2026
From Ossium Health, Inc.
Via GlobeNewswire
News headline image
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award
From Ossium Health, Inc.
Via GlobeNewswire
News headline image
Ossium Health Data on On-Demand Organ Donor Bone Marrow Selected as a Top Poster at the 2026 AABB Annual Meeting
From Ossium Health, Inc.
Via GlobeNewswire
News headline image
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility
From Ossium Health, Inc.
Via GlobeNewswire
News headline image
Ossium Health to Present New Clinical Data from PRESERVE I Study at the 2026 Tandem Meetings
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health to Present New Clinical Data on Its Organ Donor Bone Marrow at ASH 2025
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health Launches HOPE Program to Give All Patients Hope for a Cure
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health Named to Forbes’ List of America's Best Startup Employers
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health and Extremity Medical Create Strategic Partnership for Nationwide Distribution of OssiGraft Viable Bone Matrix
From Ossium Health, Inc.
Via Business Wire
News headline image
First Patient Treated with OssiGraft™
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health to Present at Cell & Gene Meeting on the Mesa
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine (CIRM) to Advance the Development of OSSM-007 for the Treatment of Steroid-Refractory Acute Graft versus Host Disease (GVHD)
From Ossium Health, Inc.
Via Business Wire
News headline image
Ossium Health Announces FDA Clearance of its Investigational New Drug Application for Treatment of Perianal Fistulizing Crohn’s Disease
From Ossium Health, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.